Opioid agonist treatment prevents hundreds of suicides: Study Australian research predicts the treatment has prevented around 300 suicide deaths among NSW patients with opioid use disorder.
TGA approves HRT patch alternatives The ongoing short supply of hormone replacement therapy patches has resulted in the approval of a range of overseas alternatives.
Study urges tailored use of MHT Shared decision-making and an individualised approach are key when it comes to MHT, but there is an ‘urgent need’ for more research.
Changes coming to MBS telehealth regulations The changes, coming into effect from 1 November, will be tied to a patient’s registered MyMedicare practice.
Puberty blocker pause leaves patients ‘languishing’ GPs caring for young trans people in Queensland will face ‘a very hard time’ following a pause on hormone therapy for under 18s.
Do GPs know enough about this ‘debilitating’ disorder? Experts agree there has been a dire lack of education around PMDD, but GPs could be in the ‘ideal situation’ to help.
TGA renews calls to limit new HRT patch prescriptions The reoccurring shortages are now expected to last until the end of 2025, raising concerns from GPs about how to support their patients long-term.
New guide to support GPs ease cancer recurrence anxiety With 60% of patients anxious their cancer will return, the three-step clinical pathway is designed to offer practical and streamlined advice.
In Practice: Call for GPs to join dementia study New research aims to gather GPs’ understanding of and attitudes to dementia diagnosis and management, and the use of blood-based biomarkers.
Promising new treatment for incurable prostate cancer Groundbreaking Australian research has unveiled a promising new treatment for patients with aggressive and therapy-resistant cancer.